中康控股(02361.HK)發售價定為每股5.36港元 預計7月12日掛牌上市
格隆匯7月11日丨中康控股(02361.HK)發佈公吿,公司全球發售7500萬股股份,其中香港發售股份750萬股,國際發售股份6750萬股,另有15%超額配股權;發售價已釐定為每股發售股份5.36港元,每手買賣單位500股;BNP PARIBAS為獨家保薦人;預期股份將於2022年7月12日於聯交所主板掛牌上市。
香港發售股份已獲適度超額認購。公司已接獲合共4352份有效申請,認購合共1660.9萬股香港發售股份,相當於根據香港公開發售初步可供認購數目約2.21倍。國際發售股份已獲略微超額認購,相當於根據國際發售初步可供認購數目約1.36倍。根據發售價每股發售股份5.36港元計算及按照基石投資協議,基石投資者已認購合共2439.6萬股發售股份。
根據發售價每股5.36港元,假設超額配股權完全未獲行使,公司自全球發售收將取的所得款項淨額估計約為3.354億港元。公司擬動用全球發售所得款項淨額約50.8%主要用於升級及提升SaaS產品(專注於智慧決策雲、智慧零售雲及智慧醫療雲)以及其營銷及推廣;約49.2%將主要用於對技術及數據倉庫進行進一步研發,特別是涉及人工智能技術,包括大數據和人工智能實驗室、公司的卓睦鳥認知醫學平台aPaaS及生命科學解決方案aPaaS,及Sinohealth Engine的中台。倘超額配股權獲悉數行使,公司將就發行1125萬股額外發售股份收取額外所得款項淨額約6030萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.